News

Filter

1 to 9 of 183 results

Strong data on Actelion’s Uptravi presented at ACC 2015

16-03-2015

Swiss biotech firm Actelion yesterday presented much anticipated positive key long-term outcome data…

ActelionBiotechnologyResearchRespiratory and PulmonaryselexipagUptravi

COPD program sponsored by AstraZeneca will create more opportunities for research

COPD program sponsored by AstraZeneca will create more opportunities for research

05-03-2015

The USA-based COPD Foundation has announced an initiative to accelerate research for chronic obstructive…

AstraZenecaPharmaceuticalResearchRespiratory and PulmonaryUSA

Cumberland Pharma expands pipeline with Boxaban progress

11-02-2015

US drugmaker Cumberland Pharmaceuticals is expanding its pipeline with a new Phase II development program.

BoxabanCumberland PharmaceuticalsPharmaceuticalResearchRespiratory and Pulmonary

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

Boehringer Ingelheim enters research pact with Yale University

Boehringer Ingelheim enters research pact with Yale University

14-01-2015

German family-owned pharma major Boehringer Ingelheim has entered into a collaboration with Yale University,…

Boehringer IngelheimGermanyImmunologicalsOncologyPharmaceuticalResearchRespiratory and Pulmonary

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

Novartis reports top-line results in COPD trials; NDA acceptance will trigger milestone for Vectura

08-01-2015

Swiss drug major Novartis today announced positive top-line results from the pivotal Phase III clinical…

MedicineNovartisPharmaceuticalQVA149ResearchRespiratory and PulmonaryUSAVecturaVectura Group

Bristol-Myers Squibb enters global research accord with Calibr

06-01-2015

US pharma major Bristol-Myer Squibb has signed a worldwide research collaboration with the California…

Bristol-Myers SquibbGlobalLicensingPharmaceuticalResearchRespiratory and Pulmonary

Vectura links with Janssen on asthma/COPD drug development

Vectura links with Janssen on asthma/COPD drug development

06-01-2015

UK inhaled therapies developer Vectura Group has entered into a global development and licence agreement…

BiotechnologyGlobalJanssen BiotechJohnson & JohnsonLicensingResearchRespiratory and PulmonaryVectura

1 to 9 of 183 results

Back to top